Amkay Products Limited
Book Built Issue IPO · BSE
- Price band
- ₹52 - ₹55
- Lot size
- 2,000 shares
- Issue amount
- ₹12.61 cr
- Total subscription
- 748.11×
- Opens
- 30 Apr 2024
- Closes
- 3 May 2024
- Allotment
- 6 May 2024
- Listing
- 8 May 2024
Offer at a glance
Issue overview
- Issue size
- 22,92,000 shares
- Face value
- ₹10 Per Equity Share
- Minimum investment
- ₹1,04,000
- Fresh issue
- ₹12.61 cr
- Offer for sale
- ₹0 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- BSE
- Maximum investment
- ₹1,10,000
- Issue type
- Book Built Issue IPO
- Shares before issue
- 63,63,640
- Shares after issue
- 86,55,640
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 2,000 | ₹1,10,000 |
| HNI | 2 | 4,000 | ₹2,20,000 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 2.39 | 413.04 |
| RETAIL | 4.19 | 4,078.41 |
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Key performance indicators
| Metric | Dec-23 | Mar-23 | Mar-22 |
|---|---|---|---|
| EPS | 3.38 | 2.37 | 2.31 |
| ROE | 24.49 | 21.69 | 26.81 |
| ROCE | 21.54 | 22.61 | 22.88 |
| RONW | 21.82 | 19.57 | 23.64 |
| PRE IPO(PE) | 3.55 | 0 | 0 |
| POST IPO(PE) | 23.18 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Founded in October 2007, Amkay Products Limited is a well-known name in India’s healthcare industry, manufacturing and supplying a wide range of medical products. Their offerings include medical devices like nebulizers and pulse oximeters, as well as disposable essentials such as face masks and alcohol swabs. Amkay’s 26,000 sq. ft. manufacturing facility in Thane, Maharashtra, is equipped with advanced machinery, a modern testing lab, and efficient handling equipment, ensuring smooth and high-quality production. The company’s strong focus on quality has earned it ISO 9001:2015 certification from QRO Certification LLP. As of December 31, 2023, Amkay employs 75 dedicated professionals, reflecting its commitment to building a skilled workforce. Despite the ever-changing healthcare landscape, the company remains focused on innovation, quality, and customer satisfaction, playing a key role in meeting healthcare needs across India.
Strengths
- Strict Quality Assurance: Amkay maintains strong quality management systems, supported by ISO 9001:2015 certification, ensuring consistent, reliable products that build customer and stakeholder confidence.
- Diversified Revenue Streams: With operations spread across multiple regions, Amkay benefits from varied market exposure, reducing dependence on any single market and improving resilience against economic fluctuations.
- Experienced Leadership: Guided by seasoned industry professionals, Amkay’s leadership brings deep expertise and a successful track record, enabling the company to overcome challenges and capture new growth opportunities.
Risk factors
- Falling Revenue Trends: The decline in revenue over the past two years raises concerns about Amkay’s ability to remain profitable and competitive amid industry and economic changes.
- History of Financial Challenges: Negative cash flows from operations, investments, and financing indicate potential liquidity issues that could affect day-to-day stability and limit future growth initiatives.
- Possibility of Continued Losses: Ongoing losses or sustained negative cash flow may make it difficult for Amkay to meet debt obligations, fund expansion, or preserve shareholder value, potentially reducing investor confidence and complicating future fundraising efforts.
Promoters
Kashyap Pravin Mody
Himanshu Kantilal Batavia
Registrar & documents
Lead manager
Hem Securities Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
Bunglow No. 68, Rashmi Park, CHS Ltd., Dhumal Nagar, Waliv Road, Vasai, Thane 401208
+91-9152094440
[email protected]Company website ↗Understanding AMKAY IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.